Los Angeles, California, United States
Contact Info
2K followers
500+ connections
About
Activity
-
"Sinclair, a global aesthetics leader, today announced the appointment of Dr. Ryan Irvine as its new Chief Development Officer. This strategic move…
"Sinclair, a global aesthetics leader, today announced the appointment of Dr. Ryan Irvine as its new Chief Development Officer. This strategic move…
Liked by Darius Lakdawalla
-
Tensions between the U.S. and China pose growing risks for the pharmaceutical industry, warned experts at the Financial Times Pharma and Biotech…
Tensions between the U.S. and China pose growing risks for the pharmaceutical industry, warned experts at the Financial Times Pharma and Biotech…
Liked by Darius Lakdawalla
-
Félicitations à ma co-auteure préférée!
Félicitations à ma co-auteure préférée!
Liked by Darius Lakdawalla
Experience & Education
Publications
-
Careful Use of Science to Advance the Debate on the UK Cancer Drugs Fund
Journal of the American Medical Association
Debate continues over the recent renewal of the UK Cancer Drugs Fund. The fund sets aside money for the National Health Service (NHS) to pay for expensive oncology medications that have not been recommended for coverage. In the United Kingdom, the National Institute for Health and Clinical Excellence (NICE) assesses the cost-effectiveness of new therapies and recommends how the NHS should allocate its fixed budget. Since 2010, a total of £1 billion (≈$1.62 billion) has been invested in the…
Debate continues over the recent renewal of the UK Cancer Drugs Fund. The fund sets aside money for the National Health Service (NHS) to pay for expensive oncology medications that have not been recommended for coverage. In the United Kingdom, the National Institute for Health and Clinical Excellence (NICE) assesses the cost-effectiveness of new therapies and recommends how the NHS should allocate its fixed budget. Since 2010, a total of £1 billion (≈$1.62 billion) has been invested in the fund, which was designed to assuage public concerns over NICE recommendations that blocked or delayed access to some new cancer drugs. The latest investment of £400 million (≈$648 million) means that current and new patients being treated with expensive oncology therapies covered by the fund can draw from it until March 2016. Although drug makers and cancer patient advocacy groups see this as a victory, some health policy researchers and analysts believe that the special cancer fund lacks coherence and fails to support evidence-based decision making.1 The debate over the Cancer Drugs Fund provides an opportunity to reconsider competing issues surrounding the allocation of health care dollars at the end of life.
Other authorsSee publication -
Malpractice Risk According to Physician Specialty
New England Journal of Medicine
Honors & Awards
-
Finalist for National Institute of Health Care Management Annual Health Care Research Award
National Institute of Health Care Management
Darius Lakdawalla, Eric Sun, Anupam Jena, Carolina Reyes, Dana Goldman, Tomas Philipson. “An economic evaluation of the war on cancer.” Journal of Health Economics 29(3): 333-346.
-
Eugene Garfield Economic Impact Award
Research America!
The Garfield Economic Impact Award recognizes outstanding research that illustrates the economic implications of research aimed at improving health or our healthcare system. Established in 2002, this annual award recognizes outstanding research demonstrating the economic impact of medical and health research, including research-based innovations in prevention, disease treatment, and health care delivery.
Dr. Lakdawalla was awarded this prize for: Lakdawalla, Darius, Dana Goldman…The Garfield Economic Impact Award recognizes outstanding research that illustrates the economic implications of research aimed at improving health or our healthcare system. Established in 2002, this annual award recognizes outstanding research demonstrating the economic impact of medical and health research, including research-based innovations in prevention, disease treatment, and health care delivery.
Dr. Lakdawalla was awarded this prize for: Lakdawalla, Darius, Dana Goldman, Pierre-Carl Michaud, Neeraj Sood, Robert Lempert, Ze Cong, Han de Vries, and Italo Gutierrez. "U.S. Pharmaceutical Policy in a Global Marketplace" Health Affairs , 28, no. 1 (2009): w138-w150. -
Milken Institute Distinguished Economic Research Prize
Milken Institute
The Milken Institute Award for Distinguished Economic Research was created in 1999 to honor the best research in economics, and is open to the academic, business and public policy communities. Entries are judged by the Institute′s professional staff, who look for original, substantive research that coincides with the Institute′s focus on the interaction of social, human and financial capital to help develop innovative means and methods to finance the future. Dr. Lakdawalla received this award…
The Milken Institute Award for Distinguished Economic Research was created in 1999 to honor the best research in economics, and is open to the academic, business and public policy communities. Entries are judged by the Institute′s professional staff, who look for original, substantive research that coincides with the Institute′s focus on the interaction of social, human and financial capital to help develop innovative means and methods to finance the future. Dr. Lakdawalla received this award for: Lakdawalla, Darius, and Tomas Philipson. "Welfare-Enhancing Technological Change and the Growth of Obesity."
More activity by Darius
-
“You travel all the time! It must be so glamorous!” Well, as I tell people, it is a biased sample because I post when I am on the road. So here I…
“You travel all the time! It must be so glamorous!” Well, as I tell people, it is a biased sample because I post when I am on the road. So here I…
Liked by Darius Lakdawalla
-
The impact of the Inflation Reduction Act and the unprecedented drug price negotiations in the US on biotech investing was a major topic at the…
The impact of the Inflation Reduction Act and the unprecedented drug price negotiations in the US on biotech investing was a major topic at the…
Liked by Darius Lakdawalla
-
EntityRisk, Inc is hiring for Student Internships https://lnkd.in/edUVZbiC
EntityRisk, Inc is hiring for Student Internships https://lnkd.in/edUVZbiC
Liked by Darius Lakdawalla
-
Great initiative Emma Walmsley. Good to see some active interest in the space. AMR has been a troubling issue for long, and the incentives for the…
Great initiative Emma Walmsley. Good to see some active interest in the space. AMR has been a troubling issue for long, and the incentives for the…
Liked by Darius Lakdawalla
-
#USCSchaeffer Center experts outlined new approaches to incorporate health equity into cost-effectiveness analysis (CEA) at the recent ISPOR—The…
#USCSchaeffer Center experts outlined new approaches to incorporate health equity into cost-effectiveness analysis (CEA) at the recent ISPOR—The…
Liked by Darius Lakdawalla
-
📍Financial Times US Pharma and Biotech Summit 2024 Industry experts gather to discuss the current investor market and how the IRA may impact the…
📍Financial Times US Pharma and Biotech Summit 2024 Industry experts gather to discuss the current investor market and how the IRA may impact the…
Liked by Darius Lakdawalla
-
Last week we were in Atlanta at #ISPOR2024 with team RA Capital Management and No Patient Left Behind (NPLB) (and a cameo from Darius Lakdawalla). We…
Last week we were in Atlanta at #ISPOR2024 with team RA Capital Management and No Patient Left Behind (NPLB) (and a cameo from Darius Lakdawalla). We…
Liked by Darius Lakdawalla
-
Attention all potential interns attending #ISPORAnnual - we are #hiring a remote summer Pharm.D. intern - see our listing at…
Attention all potential interns attending #ISPORAnnual - we are #hiring a remote summer Pharm.D. intern - see our listing at…
Liked by Darius Lakdawalla
-
Today, I was honored to share with the Senate HELP Committee our USC Schaeffer Center for Health Policy & Economics research into policies for…
Today, I was honored to share with the Senate HELP Committee our USC Schaeffer Center for Health Policy & Economics research into policies for…
Shared by Darius Lakdawalla
-
Honored to receive Value in Health's "Paper of the Year Award" (and thanks to co-authors, Lou Garrison & Richard Willke) for our paper: “The History…
Honored to receive Value in Health's "Paper of the Year Award" (and thanks to co-authors, Lou Garrison & Richard Willke) for our paper: “The History…
Liked by Darius Lakdawalla
-
After two years of development and testing, this morning we're officially launching the new PROVEN platform. See the press release here -…
After two years of development and testing, this morning we're officially launching the new PROVEN platform. See the press release here -…
Liked by Darius Lakdawalla
-
After eighteen truly wonderful years at RAND Corporation, it is a pleasure and an honor to continue my professional journey and commitment to…
After eighteen truly wonderful years at RAND Corporation, it is a pleasure and an honor to continue my professional journey and commitment to…
Liked by Darius Lakdawalla
Other similar profiles
-
Dana P Goldman
Founding Director, USC Schaeffer Institute | University Professor of Public Policy, Pharmacy, and Economics | Former Dean
Connect -
Seth Seabury
Associate Professor
Connect -
Jason Shafrin
Senior Managing Director, Center for Healthcare Economics & Policy at FTI Consulting; Adjunct Professor, University of Southern California
Connect -
Matthew E. Kahn
Connect -
John Romley
Associate Professor of Public Policy
Connect -
Erin Trish
Co-Director at Leonard D. Schaeffer Center for Health Policy & Economics
Connect -
Geoffrey Joyce
Associate Professor at University of Southern California
Connect -
Devin Incerti
Connect -
Ken S. Wong
Director and Associate Professor at University of Southern California
Connect -
Steve Sapra
Founder & CEO, ULTIMUM LLC, Professor of the Practice of Economics, University of Southern California, Co-Director USC Math Finance Master's Program, ex-PIMCO
Connect
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More